Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by University of Pittsburgh
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Jennifer Rubin Grandis, University of Pittsburgh Identifier:
First received: May 14, 2009
Last updated: April 14, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2021
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)